Jefferies on Eli Lilly (LLY) competition: Oral Wegovy's TRx came in at ~94.7k on IMS & ~80.1k on Symphony
Tweet Send to a Friend
Jefferies analyst Akash Tewari reiterated a Buy rating and $1,300.00 price target on Eli Lilly (NYSE: LLY)The analyst commented, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
